Tag: Zydus Cadila
Zydus Cadila gets USFDA nod for Anti Depressant drug
Zydus Cadila has received final approval from the USFDA to market Nortriptyline Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg and...
Zydus Cadila gets USFDA nod for low Blood Pressure drug
Zydus Cadila on Friday said it has received final approval from the US health regulator to market Droxidopa capsules, used to treat low blood pressure.
Zydus Cadila gets USFDA nod for Thyroid drug
New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to treat underactive thyroid....
NPPA fixes retail price of 7 formulations
National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of three formulations under Drugs Prices Control Order (DPCO) – 2013 vide notification no....
Zydus Cadila gets tentative USFDA approval for Linagliptin Tablets
Zydus Cadila has received tentative approval from the USFDA to market Linagliptin Tablets, 5 mg (US RLD: Tradjenta Tablets).
Zydus Cadila gets tentative USFDA approval for Dapagliflozin Tablets
Zydus Cadila has received tentative approval from the USFDA to market Dapagliflozin Tablets, 5 mg and 10 mg (US RLD: Farxiga Tablets)....
Zydus Cadila gets USFDA nod to market Albuterol tablets
Zydus Cadila has received final approval from the US Food & Drug Administration (FDA) to market albuterol tablets in the strengths of...
Zydus Cadila gets USFDA nod for bladder treatment drug
Drug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator to market Solifenacin Succinate tablets, used for treatment of...
Zydus Cadila gets tentative USFDA nod for Tofacitinib ER tablets
Zydus Cadila has received tentative approval from the USFDA to market Tofacitinib Extended-Release Tablets, 11 mg (US RLD: Xeljanz XR Tablets).
Zydus Cadila gets USFDA nod for Ursodiol capsules
New Delhi: Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Ursodiol capsules,...
Zydus Cadila gets USFDA Nod for Fingolimod cap, Verapamil HCL inj.
Zydus Cadila has received final approval from the USFDA to market Fingolimod Capsules, 0.5 mg (US RLD: Gilenya Capsules).
6 Indian drug Cos to set up a large pharma cluster...
Hyderabad: 6 generic drug makers –– Dr Reddy’s Laboratories, Zydus Cadila, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Hetero Drugs and Ackerman Pharma –– have signed a deal with...
Zydus Cadila launches COPD drug in India
New Delhi: Drug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) in...
Zydus Cadila & Cipla gets USFDA nod for dimethyl fumarate DR...
Zydus Cadila
Zydus Cadila has received final approval from the USFDA to market dimethyl fumarate delayed-release capsules, (US...
Zydus Cadila gets tentative USFDA nod for anti-cancer drug
Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules.
Zydus Cadila gets USFDA nod for mineral supplement
Zydus Cadila has received final approval from the USFDA to market potassium chloride extended-release tablets (US RLD: K-Dur Extended-Release Tablets) in the...
Zydus Cadila gets USFDA nod for Doxorubicin HCL Liposome Injection
Zydus Cadila has received final approval from the USFDA to market Doxorubicin Hydrochloride Liposome Injection (US RLD: Doxil Liposome Injection) in the...
Zydus Cadila gets tentative nod for generic diabetes drug
New Delhi: Drug firm Zydus Cadila on Wednesday said it has received approval from the US health regulator to market diabetes drug, Empagliflozin and Linagliptin tablets, in the US...
Zydus Cadila gets USFDA nod to market midodrine HCL tablets
Zydus Cadila received final approval from the USFDA to market Midodrine Hydrochloride Tablets (US RLD- ProAmatine Tablets) in the strengths of 2.5...
Zydus Cadila gets USFDA nod for Cisatracurium Besylate Inj
Zydus Cadila has received final approval from the United States Food and Drugs Administration (USFDA) to market Cisatracurium Besylate Injection USP (US...
India’s cheapest remdesivir launched by Zydus Cadila: Rs 2,800 per vial
BENGALURU: Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in...
Zydus Cadila gets tentative USFDA nod for Carbidopa and Levodopa caps
Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of 23.75 mg/95...
Zydus Cadila gets nod from USFDA for tension headache tablets
NEW DELHI: Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine...
Zydus Cadila gets USFDA nod for Doxycycline Inj.
NEW DELHI: Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator for manufacturing Doxycycline Injection at its Jarod facility,...